1.
J Antimicrob Chemother
; 78(9): 2377-2379, 2023 09 05.
Article
in English
| MEDLINE
| ID: mdl-37392133
Subject(s)
Aztreonam , Klebsiella Infections , Humans , Meropenem/therapeutic use , Aztreonam/pharmacology , Aztreonam/therapeutic use , Klebsiella pneumoniae , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , beta-Lactamases , Drug Combinations , Microbial Sensitivity Tests , Klebsiella Infections/drug therapy
2.
Clin Infect Dis
; 72(11): 2021-2024, 2021 06 01.
Article
in English
| MEDLINE
| ID: mdl-32941593
ABSTRACT
Ten critically ill patients with either bacteremia or ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii, Stenotrophomonas maltophilia, or New Delhi metallo-ß-lactamase-producing Klebsiella pneumoniae received cefiderocol. All strains had minimum inhibitory concentration ≤2 µg/mL. Thirty-day clinical success and survival rates were 70% and 90%, respectively. Two patients had a microbiological failure. Future prospective studies are warranted.